These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

33 related articles for article (PubMed ID: 15336596)

  • 1. A novel T cell cytokine, secreted osteoclastogenic factor of activated T cells, induces osteoclast formation in a RANKL-independent manner.
    Rifas L; Weitzmann MN
    Arthritis Rheum; 2009 Nov; 60(11):3324-35. PubMed ID: 19877052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone density and hyperlipidemia: the T-lymphocyte connection.
    Graham LS; Tintut Y; Parhami F; Kitchen CM; Ivanov Y; Tetradis S; Effros RB
    J Bone Miner Res; 2010 Nov; 25(11):2460-9. PubMed ID: 20533376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-Dose Staphylococcal Enterotoxin C2 Mutant Maintains Bone Homeostasis via Regulating Crosstalk between Bone Formation and Host T-Cell Effector Immunity.
    Wang H; Lin S; Feng L; Huang B; Lu X; Yang Z; Jiang Z; Li YC; Zhang X; Wang M; Wang B; Kong L; Pan Q; Bai S; Li Y; Yang Y; Lee WYW; Currie PD; Lin C; Jiang Y; Chen J; Tortorella MD; Li H; Li G
    Adv Sci (Weinh); 2023 Oct; 10(28):e2300989. PubMed ID: 37552005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metatranscriptome sequencing identifies
    Radzieta M; Malone M; Ahmad M; Dickson HG; Schwarzer S; Jensen SO; Lavery LA
    Front Microbiol; 2022; 13():956332. PubMed ID: 35979499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone-immune cell crosstalk: bone diseases.
    Mori G; D'Amelio P; Faccio R; Brunetti G
    J Immunol Res; 2015; 2015():108451. PubMed ID: 26000310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T cells from chronic bone infection show reduced proliferation and a high proportion of CD28⁻ CD4 T cells.
    Kumar G; Roger PM; Ticchioni M; Trojani C; Bernard de Dompsur R; Bronsard N; Carles M; Bernard E
    Clin Exp Immunol; 2014 Apr; 176(1):49-57. PubMed ID: 24298980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activated γδ T cells inhibit osteoclast differentiation and resorptive activity in vitro.
    Pappalardo A; Thompson K
    Clin Exp Immunol; 2013 Nov; 174(2):281-91. PubMed ID: 23815433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hairy and Enhancer of Split-related with YRPW motif (HEY)2 regulates bone remodeling in mice.
    Zanotti S; Canalis E
    J Biol Chem; 2013 Jul; 288(30):21547-57. PubMed ID: 23782701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Porphyromonas gingivalis infection-associated periodontal bone resorption is dependent on receptor activator of NF-κB ligand.
    Han X; Lin X; Yu X; Lin J; Kawai T; LaRosa KB; Taubman MA
    Infect Immun; 2013 May; 81(5):1502-9. PubMed ID: 23439308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HES1 (hairy and enhancer of split 1) is a determinant of bone mass.
    Zanotti S; Smerdel-Ramoya A; Canalis E
    J Biol Chem; 2011 Jan; 286(4):2648-57. PubMed ID: 21084301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The immune system and bone.
    Pacifici R
    Arch Biochem Biophys; 2010 Nov; 503(1):41-53. PubMed ID: 20599675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of T cells in osteoporosis, an update.
    Zhao W; Liu Y; Cahill CM; Yang W; Rogers JT; Huang X
    Int J Clin Exp Pathol; 2009 May; 2(6):544-52. PubMed ID: 19636401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alpha1beta1 integrin and interleukin-7 receptor up-regulate the expression of RANKL in human T cells and enhance their osteoclastogenic function.
    Gendron S; Boisvert M; Chetoui N; Aoudjit F
    Immunology; 2008 Nov; 125(3):359-69. PubMed ID: 18479350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-10 inhibits gram-negative-microbe-specific human receptor activator of NF-kappaB ligand-positive CD4+-Th1-cell-associated alveolar bone loss in vivo.
    Zhang X; Teng YT
    Infect Immun; 2006 Aug; 74(8):4927-31. PubMed ID: 16861684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of activated T cells on osteoclastogenesis depend on how they are activated.
    Wyzga N; Varghese S; Wikel S; Canalis E; Sylvester FA
    Bone; 2004 Sep; 35(3):614-20. PubMed ID: 15336596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activated T lymphocytes suppress osteoclastogenesis by diverting early monocyte/macrophage progenitor lineage commitment towards dendritic cell differentiation through down-regulation of receptor activator of nuclear factor-kappaB and c-Fos.
    Grcević D; Lukić IK; Kovacić N; Ivcević S; Katavić V; Marusić A
    Clin Exp Immunol; 2006 Oct; 146(1):146-58. PubMed ID: 16968409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Regulation of osteoclastogenesis by activated T cells].
    Sato K; Takayanagi H
    Nihon Rinsho; 2005 Sep; 63(9):1529-32. PubMed ID: 16164207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T-cells mediate an inhibitory effect of interleukin-4 on osteoclastogenesis.
    Mirosavljevic D; Quinn JM; Elliott J; Horwood NJ; Martin TJ; Gillespie MT
    J Bone Miner Res; 2003 Jun; 18(6):984-93. PubMed ID: 12817750
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.